HLB Therapeutics Co.,Ltd. (115450.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−32.2x

Market Cap

KRW 175.77B

MomentumView details →

1D Return

+0.96%

YTD Return

−28.33%

RSI (14)

53.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−32.2x

Market Cap

KRW 175.77B

RSI (14)

53.1

MomentumView details →

1D Return

+0.96%

YTD Return

−28.33%

ProfitabilityView details →

Gross Margin

6.29%

Net Margin

−25.15%

EBITDA Margin

−10.98%

ROE (TTM)

−11.28%

ROA (TTM)

−7.36%

Asset Turnover

0.29x

GrowthView details →

Revenue YoY

+5.50%

EPS YoY

—

FCF YoY

+38.66%

Revenue CAGR 3Y

+18.03%

EPS CAGR 3Y

+63.66%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−KRW 49.00

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.28x

Current Ratio

0.78x

Quick Ratio

0.64x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

64.60B

Net Income (TTM)

−16.25B

Op. CF (TTM)

−1.17B

Latest newsMore news →

No recent news for 115450.KQ.

Similar companies

WuXi Biologics (Cayman) Inc.02269.HK Green Cross Holdings Corporation005257.KS EASY BIO,Inc.353810.KQ Genexine, Inc.095700.KQ Anterogen.Co.,Ltd.065660.KQ BINEX Co., Ltd.053030.KQ Find similar companies →

Latest newsMore news →

No recent news for 115450.KQ.